Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
40 participants
INTERVENTIONAL
2023-06-29
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Auditory Stimulation
Auditory Stimulation during sleep
Auditory Stimulation
enhancement of sleep slow wave activity through acoustic stimulation
No Auditory Stimulation
Playing no tones during sleep but still recording brain activity
Sham (no stimulation)
Playing no tones during sleep but still recording brain activity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Auditory Stimulation
enhancement of sleep slow wave activity through acoustic stimulation
Sham (no stimulation)
Playing no tones during sleep but still recording brain activity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to provide written and verbal informed consent
* Fluency in the German language
* Stable home situation that allows for reliable application of the intervention for the duration of the study
* Ability to apply the intervention for the duration of the study, either alone or with support from a co-habitant
* For women: Hormonal contraception, if menstrual cycle is still present or has been present within a year
* Good general health status, normal cognitive function
Exclusion Criteria
* Inability to follow the procedures of the investigation
* For women: pregnancy or breastfeeding
* Presence of sleep disorders (e.g. sleep apnoea, narcolepsy, restless leg syndrome, insomnia, rapid eye movement (REM) sleep disorder)
* Shift-work or a home situation that requires several awakenings during the night (e.g. newborn)
* History of serious illness likely to interfere with study outcomes
* Presence or history of a diagnosed neuropsychiatric illness
* Current diagnosis of uncontrolled or poorly controlled diabetes
* Current cancer of the brain or unstable cancer undergoing treatment
* Evidence of serious atherosclerotic cardiovascular disease
50 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
University Children's Hospital, Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anton Gietl
Role: PRINCIPAL_INVESTIGATOR
Institute for Regenerative Medicine, University of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Regenerative Medicine, University Hospital Zurich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BBCDS
Identifier Type: -
Identifier Source: org_study_id